Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio for $4.9 billion
On Sept. 22, 2025, Pfizer and Metsera announced the companies have entered into a definitive agreement under which…
Bill Gates pledges $912 million to global disease fight, urges governments to step up
On Sept. 22, 2025, The Gates Foundation will give $912 million to the Global Fund to Fight AIDS,…
FDA Takes Action to Make a Treatment Available for Autism Symptoms
On Sept. 22, 2025, the U.S. Food and Drug Administration (FDA) announced it h initiated the approval of…
Over 400,000 turkeys euthanized in South Dakota due to bird flu
On Sept. 22, 2025, the U.S. Department of Agriculture (USDA) reported that over 400,000 turkeys have been euthanized…
Mexico Confirms Case of New World Screwworm in Nuevo Leon
On Sept. 21, 2025, Mexico’s National Service of Agro-Alimentary Health, Safety, and Quality (SENASICA) confirmed a new case…
Biotechnology | CDC | COVID-19 | Diagnostics | Genomics | Infectious Disease | Measles | NIH | Polio | Vaccine | Women's Health
CDPH and West Coast Health Alliance Release Statement Responding to ACIP Updates to National Vaccine Recommendations
On Sept. 19, 2025, the state health officials of the members of the West Coast Health Alliance, including…
Biotechnology | CDC | COVID-19 | Infectious Disease | NIH | Vaccine
Kennedy’s vaccine advisers change COVID shot guidance, calling them an individual choice
On Sept. 19, 2025, Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers added confusion to this fall’s…
The tale of the creature with the most chromosomes
On Sept. 19, 2025, researchers at the Wellcome Sanger Institute and the Institute of Evolutionary Biology, Barcelona reported…
Biogen to Acquire Alcyone Therapeutics for $85 million, Expanding Drug Delivery Solution Portfolio
On Sept. 18, 2025, Biogen announced it has has entered into a definitive agreement to acquire Massachusetts-based Alcyone…
Biogen Receives EC Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
On Sept. 17, 2025, Biogen announced that the European Commission (EC) has granted marketing authorization for ZURZUVAE® (zuranolone)…
Roche to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH for US $3.5 billion
On Sept. 17, 2025, Roche announced that it has entered into a definitive merger agreement to acquire 89bio,…
GSK to invest $30 billion in R&D and Manufacturing in the U.S. over next 5 years
On Sept. 17, 2025, GSK announced plans to invest $30 billion across the United States in research and…
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill) delivered 16.6% weight loss in people with obesity in a newly published study
On Sept. 17, 2025, The New England Journal of Medicine published the results from the OASIS 4 phase…
Lilly announces plans to build $5 billion manufacturing facility in Virginia
On Sept. 16, 2025, Eli Lilly announced that it plans to build a $5 billion manufacturing facility just…
New University of Alberta health institute will help research breakthroughs reach patients sooner
On Sept. 15, 2025, the University of Alberta (U of A) announced the Dianne and Irving Kipnes Health…
Biotechnology | Disease | FDA | Therapeutics
Corstasis Therapeutics Announces FDA Approval of ENBUMYST™ (bumetanide nasal spray) for the Treatment of Edema Associated with Congestive Heart Failure, Liver Disease and Kidney Disease
On Sept. 15, 2025, Corstasis Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved ENBUMYST™…
Agriculture | Diagnostics | FDA | Infectious Disease | Influenza | USDA
USDA Confirms Highly Pathogenic Avian Influenza in Dairy Herd in Nebraska
On Sept. 15, 2025, the U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) National…
Ebola vaccination begins in the Democratic Republic of the Congo
On Sept. 14, 2025, the World Health Organization announced that vaccination of frontline health workers and contacts of…
gene therapy offers hope for genetic hearing loss
On Sept. 14, 2025, scientists from the Gray Faculty of Medical & Health Sciences at Tel Aviv University…
Corn diseases lurk in bumper US crop, threatening yields
On Sept. 12, 2025, high levels of fungal disease are lurking in corn fields across the U.S. Midwest,…
3D bioprinted mini placentas could transform pregnancy research
On Sept. 12, 2025, scientists from the University of Technology Sydney (UTS) announced they have achieved a major…
Melinda French Gates launches $100 million push for women’s health research
On Sept. 10, 2025, philanthropist Melinda French Gates announces she will invest $50 million in a women’s health…
Merck to scrap London drug research centre
On Sept. 10, 2025, Merck announced it was scrapping research operations in London, citing the UK’s challenging business…
Utah Health Officials Report Large Measles Exposure
On Sept. 10, 2025, the Utah Department of Health and Human Services (UDOH) reported a potential large exposure…
UK trial launches to transform Alzheimer’s diagnosis with simple blood test
On Sept. 10, 2025, a major University of London (UCL)-led clinical trial, aiming to transform the diagnosis of…
NASA’s Mars Rover Discovered Potential Biosignature
On Sept. 10, 2025, the National Aeronautics and Space Administration (NASA) announced that a sample collected by NASA’s…
Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test
On Sept. 10, 2025, Exact Sciences announced the launch of the Cancerguard™ test, a new multi-cancer early detection…
Novartis to acquire Tourmaline Bio and pipeline for atherosclerotic cardiovascular disease, valued at $1.4 Billion
On Sept. 9, 2025, Novartis announced that it has entered into an agreement to acquire Tourmaline Bio, a…
Emergent BioSolutions Receives New Contract for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
On Sept. 9, 2025, Emergent BioSolutions announced that a contract modification has been executed in the amount of…
Lilly launches TuneLab platform to give biotech companies access to AI-enabled drug discovery models with over $1 billion in research investment
On Sept. 9, 2025, Eli Lilly announced the launch of Lilly TuneLab, an artificial intelligence and machine learning…